Anbio Biotechnology (NNNN)

May 05, 2026

Why Anbio Biotechnology Class A Shares Are Surging - TipRanks

May 05, 2026

May 04, 2026

Why Anbio Biotechnology Class A Shares Are Jumping - TipRanks

May 04, 2026

Apr 30, 2026

Free cash flow per share of Anbio Biotechnology Class A – FWB:N3B - TradingView

Apr 30, 2026

Apr 27, 2026

Anbio Biotechnology Calls May 15 Shareholder Votes on Sweeping Capital and Governance Overhaul - TipRanks

Apr 27, 2026

Apr 27, 2026

Anbio Biotechnology (NNNN) seeks huge capital increase and 500-vote Class B shares - Stock Titan

Apr 27, 2026

Apr 27, 2026

Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks

Apr 27, 2026

Apr 22, 2026

Top Maplight Therapeutics (MPLT) Competitors 2026 - MarketBeat

Apr 22, 2026

Apr 22, 2026

Why Anbio Biotechnology Shares Are Suddenly Surging - TipRanks

Apr 22, 2026

Apr 22, 2026

Anbio (NNNN) Stock Volume Drop (Buying Pressure) 2026-04-22Trending Buy Opportunities - Newser

Apr 22, 2026

Apr 19, 2026

Anbio Biotechnology posts solid FY25 results, diversifies portfolio - MSN

Apr 19, 2026

Apr 18, 2026

Cany Xu Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 18, 2026

Nancy Hartzler Net Worth (2026) - GuruFocus

Apr 18, 2026

Apr 17, 2026

Suki Song Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Michael Lau Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Chris Tian Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 15, 2026

Why Anbio Biotechnology Shares Are Sliding Fast - TipRanks

Apr 15, 2026

Apr 15, 2026

Anbio Biotechnology (NASDAQ:NNNN) Trading Down 5.5%Here's What Happened - MarketBeat

Apr 15, 2026

Apr 14, 2026

Assessing Anbio Biotechnology (NNNN) Valuation After Sharp Swings And A Rich Price To Book Multiple - simplywall.st

Apr 14, 2026

Apr 13, 2026

Anbio Biotechnology Broadens Test Portfolio And Shifts Risk Profile - Sahm

Apr 13, 2026

Apr 13, 2026

Is Anbio (NNNN) Stock Discounted Now | Price at $27.63, Up 1.96%Verified Stock Signals - Newser

Apr 13, 2026

Apr 10, 2026

Anbio Biotechnology Posts Solid FY25 Results, Diversifies Portfolio - Sahm

Apr 10, 2026

Apr 10, 2026

Is Anbio (NNNN) Stock Good for Beginners | Price at $26.77, Down 0.28%Verified Stock Signals - Newser

Apr 10, 2026

Apr 09, 2026

Form 20-F/AAnnual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend] - ADVFN

Apr 09, 2026

Apr 09, 2026

Discovering US Undiscovered Gems for April 2026 - simplywall.st

Apr 09, 2026

Apr 09, 2026

Anbio Biotechnology (NNNN) files 20-F/A to mark well-known seasoned issuer - Stock Titan

Apr 09, 2026

Apr 08, 2026

Anbio Biotechnology (ANBF) Non Cash 74.1% Net Margin Fuels Fresh Debate On Earnings Quality - simplywall.st

Apr 08, 2026

Apr 08, 2026

Anbio Biotechnology | 3: Initial statement of beneficial ownership of securities- Hartzler Nancy - Moomoo

Apr 08, 2026

Apr 08, 2026

Anbio Biotechnology (NNNN) CEO Michael Lau identified as insider in Form 3 - Stock Titan

Apr 08, 2026

Apr 08, 2026

Anbio Biotechnology (NNNN) director XU CANY files initial Form 3 - Stock Titan

Apr 08, 2026

Apr 08, 2026

Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks

Apr 08, 2026

Apr 07, 2026

Super-voting control and post-COVID shift at Anbio Biotechnology (Nasdaq: NNNN) - Stock Titan

Apr 07, 2026

Apr 07, 2026

Anbio Biotechnology Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

Apr 07, 2026

Apr 06, 2026

Will Anbio (NNNN) Stock Hit New Highs | Price at $26.40, Up 2.13%Community Trade Ideas - Newser

Apr 06, 2026

Mar 30, 2026

Exxon Mobil, Pepsico among market cap stock movers on Monday - Investing.com UK

Mar 30, 2026

Mar 30, 2026

Exxon Mobil, Pepsico among market cap stock movers on Monday By Investing.com - Investing.com Canada

Mar 30, 2026

Mar 30, 2026

Anbio Biotechnology (NNNN) Surges 11.6% Intraday – What’s Fueling the Volatility? - Bitget

Mar 30, 2026

Mar 18, 2026

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum - The Manila Times

Mar 18, 2026

Mar 17, 2026

Anbio Biotechnology to Participate in KeyBanc Capital Markets Healthcare Forum on March 17, 2026 - geneonline.com

Mar 17, 2026

Mar 17, 2026

Anbio CEO to outline rapid diagnostic plans at KeyBanc investor event - Stock Titan

Mar 17, 2026

Mar 14, 2026

Aktis Oncology (AKTS) Stock Analysis Report | Financials & Insights - Benzinga Japan

Mar 14, 2026

Mar 09, 2026

Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World

Mar 09, 2026

Mar 08, 2026

Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today

Mar 08, 2026

Mar 07, 2026

Anbio Biotechnology falls -5.8% - MSN

Mar 07, 2026

Mar 07, 2026

Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Mar 07, 2026

Mar 06, 2026

Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Mar 06, 2026

Mar 04, 2026

Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge

Mar 04, 2026

Mar 04, 2026

Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World

Mar 04, 2026

Mar 04, 2026

Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World

Mar 04, 2026

Mar 04, 2026

TechTarget (TTGT) to Release Earnings on Wednesday - Defense World

Mar 04, 2026